Cargando…

Genetic and Epigenetic of Medullary Thyroid Cancer

Medullary thyroid carcinoma (MTC) is an infrequent calcitonin-producing neuroendocrine tumor that initiates from the parafollicular C cells of the thyroid gland. Several genetic and epigenetic alterations are collaterally responsible for medullary thyroid carcinogenesis. In this review article, we s...

Descripción completa

Detalles Bibliográficos
Autores principales: Khatami, Fatemeh, Tavangar, Seyed Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pasteur Institute 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889499/
https://www.ncbi.nlm.nih.gov/pubmed/29126344
http://dx.doi.org/10.22034/ibj.22.3.142
_version_ 1783312708680024064
author Khatami, Fatemeh
Tavangar, Seyed Mohammad
author_facet Khatami, Fatemeh
Tavangar, Seyed Mohammad
author_sort Khatami, Fatemeh
collection PubMed
description Medullary thyroid carcinoma (MTC) is an infrequent calcitonin-producing neuroendocrine tumor that initiates from the parafollicular C cells of the thyroid gland. Several genetic and epigenetic alterations are collaterally responsible for medullary thyroid carcinogenesis. In this review article, we shed light on all the genetic and epigenetic hallmarks of MTC. From the genetic perspective, RET, HRAS, and KRAS are the most important genes that are characterized in MTC. From the epigenetic perspective, Ras-association domain family member 1A, telomerase reverse transcriptase promoter methylations, overexpression of histone methyltransferases, EZH2 and SMYD3, and wide ranging increase and decrease in non-coding RNAs can be responsible for medullary thyroid carcinogenesis.
format Online
Article
Text
id pubmed-5889499
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Pasteur Institute
record_format MEDLINE/PubMed
spelling pubmed-58894992018-05-01 Genetic and Epigenetic of Medullary Thyroid Cancer Khatami, Fatemeh Tavangar, Seyed Mohammad Iran Biomed J Review Article Medullary thyroid carcinoma (MTC) is an infrequent calcitonin-producing neuroendocrine tumor that initiates from the parafollicular C cells of the thyroid gland. Several genetic and epigenetic alterations are collaterally responsible for medullary thyroid carcinogenesis. In this review article, we shed light on all the genetic and epigenetic hallmarks of MTC. From the genetic perspective, RET, HRAS, and KRAS are the most important genes that are characterized in MTC. From the epigenetic perspective, Ras-association domain family member 1A, telomerase reverse transcriptase promoter methylations, overexpression of histone methyltransferases, EZH2 and SMYD3, and wide ranging increase and decrease in non-coding RNAs can be responsible for medullary thyroid carcinogenesis. Pasteur Institute 2018-05 /pmc/articles/PMC5889499/ /pubmed/29126344 http://dx.doi.org/10.22034/ibj.22.3.142 Text en Copyright: © Iranian Biomedical Journal http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Khatami, Fatemeh
Tavangar, Seyed Mohammad
Genetic and Epigenetic of Medullary Thyroid Cancer
title Genetic and Epigenetic of Medullary Thyroid Cancer
title_full Genetic and Epigenetic of Medullary Thyroid Cancer
title_fullStr Genetic and Epigenetic of Medullary Thyroid Cancer
title_full_unstemmed Genetic and Epigenetic of Medullary Thyroid Cancer
title_short Genetic and Epigenetic of Medullary Thyroid Cancer
title_sort genetic and epigenetic of medullary thyroid cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889499/
https://www.ncbi.nlm.nih.gov/pubmed/29126344
http://dx.doi.org/10.22034/ibj.22.3.142
work_keys_str_mv AT khatamifatemeh geneticandepigeneticofmedullarythyroidcancer
AT tavangarseyedmohammad geneticandepigeneticofmedullarythyroidcancer